Cancer ScreeningNCT05016570
The Impact of Picture Narrative Format on Print Lung Screening Communication Outcomes
A study testing Picture narrative information format, Text with pictures information format and Text-only information format in people with Cancer Screening, run by University of Glasgow at 1 site in United Kingdom.
Trial summary
The purpose of this study is to test whether a picture narrative format is more successful, than text with pictures or text alone, in communicating lung screening information (primarily defined by positive attitudes towards the design and increase in knowledge) to people likely to be invited to lung screening where… Read more about this study
- Who is it for?
- Ages 49 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Cancer Screening
- What is being tested?
- Picture narrative information format, Text with pictures information format and Text-only information format
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 326 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 27 Aug 2021to 8 Oct 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 49 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Living in Glasgow
- Willing and able to respond unaided to invitation to participate in the trial and give informed consent.
- Aged between 49 and 75 years
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Mental Health and Wellbeing, University of Glasgow
Glasgow, G12 0XH
About this study
Official title: The Impact of Picture Narrative Format on Knowledge and Acceptability for Lung Screening Print Decision Support Materials
The purpose of this study is to test whether a picture narrative format is more successful, than text with pictures or text alone, in communicating lung screening information (primarily defined by positive attitudes towards the design and increase in knowledge) to people likely to be invited to lung screening where available.
Read the detailed description
Population screening is key to detecting lung cancer early at a more treatable stage. Uptake of screening should be equitable (i.e., screening benefits all eligible members of the population and does not contribute further to health disparities) and informed (i.e., participants have been involved in the decision to take part and their decision aligns with their values and circumstances). Print decision support materials are the primary mechanism for encouraging engagement with cancer screening and supporting decision making. It is essential that we identify print communication techniques that are effective in informing invitees about lung screening.
The intervention, picture narrative information about lung screening, was previously developed through codesign and prototype testing with people likely to be eligible for lung screening (50 to 75 years old, past or current heavy smokers). Participants will be randomised to one of three groups: Picture narrative format, Text with pictures (control 1) or, Text-only (control 2). This study will assess whether presenting lung screening information in a picture narrative format can improve lung cancer screening knowledge, eligibility self-assessment and attitudes. It will also assess whether perceptions of the information designs can explain any impact of the intervention on these outcomes and whether there are differences across socioeconomic groups.
- Conditions
- Cancer Screening
- Being tested
- Picture narrative information format, Text with pictures information format, Text-only information format
- Keywords
- Health Communication, Lung cancer screening, Messages, Comprehension, Visual, Narrative, Comics
- Medical subject headings
- Narration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Picture narrative information formatBehavioural
Lung screening information formatted as picture narratives
Text with pictures information formatBehavioural
Lung screening information formatted as text and non-narrative pictures
Text-only information formatBehavioural
Lung screening information formatted as text with no pictures
| Study group | Role | What they receive |
|---|---|---|
| Picture narrative lung screening information | Experimental | Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format which uses text in combination with sequences of pictures to communicate a coherent message. The designs follow conventions from comics/graphic narratives and key stakeholders were involved during the design process. Receives: Behavioral: Picture narrative information format |
| Text with pictures lung screening information | Active comparator | Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text with non-narrative pictures for decoration. The pictures have been extracted from the picture narratives being used Arm 1. Receives: Behavioral: Text with pictures information format |
| Text-only lung screening information | Active comparator | Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text and no pictures. Receives: Behavioral: Text-only information format |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant Lung Cancer Screening Knowledge scores
Participants will be asked 6 multiple choice questions related to the lung screening information presented to the participants during the intervention, covering; Procedure, Eligibility - who, Eligibility - why, Benefits, Adverse effects, Potential results.
Measured: Immediately post-intervention
Lung Cancer Screening Eligibility self-assessment
Concordance between self-reported personal eligibility for lung cancer screening and actual eligibility based on self-reported age and smoking behaviour.
Measured: Immediately post-intervention
Participant Lung Cancer Screening Attitudes
Self-administered four-item lung cancer screening attitudes measure covering cancer fear, fatalism, benefits, and worry, previously used by Smits et al 2018.
Measured: Immediately post-intervention
Secondary outcomes (1)
Participant Design appraisal ratings
Self-administered nine-item measure rating perceptions of appeal, enjoyment, interest, ease of use, trustworthiness, appropriateness, helpfulness, informativity.
Alongside a single item asking participants whether enough information was provided.
Measured: Immediately post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Aug 2021
- Study start27 Aug 2021
- Primary completion8 Oct 2021
- Study completion8 Oct 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer ScreeningStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants are randomly assigned to one of three groups. They will receive the same lung screening information but the format of this information will be determined by which group they have been randomised to. All participants will complete a questionnaire immediately after viewing the lung screening information.
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 326 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Glasgow
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Katie Robb, University of Glasgow
- Investigators
- Kathryn Robb, PhD, Principal investigator, University of Glasgow
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05016570
- Sponsor's protocol ID
- 200200021
- Status last verified
- Oct 2021
- First submitted
- 17 Aug 2021
- Last updated
- 26 Oct 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymised individual level study data will be shared via the University of Glasgow's repository Enlighten: Research Data.
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of Picture Narrative Format on Knowledge and Acceptability for Lung Screening Print Decision Support Materials
- ClinicalTrials.gov ID
- NCT05016570
- Acronym / sponsor ID
- 200200021
- Conditions
- Cancer Screening
- Keywords
- Health Communication, Lung cancer screening, Messages, Comprehension, Visual, Narrative, Comics
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 326 participants (actual)
- Lead sponsor
- University of GlasgowUniversity, hospital or other
- Study start
- 27 Aug 2021 (actual)
- Primary completion
- 8 Oct 2021 (actual)
- Study completion
- 8 Oct 2021 (actual)
- First posted
- 23 Aug 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to test whether a picture narrative format is more successful, than text with pictures or text alone, in communicating lung screening information (primarily defined by positive attitudes towards the design and increase in knowledge) to people likely to be invited to lung screening where available.
Detailed description
Population screening is key to detecting lung cancer early at a more treatable stage. Uptake of screening should be equitable (i.e., screening benefits all eligible members of the population and does not contribute further to health disparities) and informed (i.e., participants have been involved in the decision to take part and their decision aligns with their values and circumstances). Print decision support materials are the primary mechanism for encouraging engagement with cancer screening and supporting decision making. It is essential that we identify print communication techniques that are effective in informing invitees about lung screening.
The intervention, picture narrative information about lung screening, was previously developed through codesign and prototype testing with people likely to be eligible for lung screening (50 to 75 years old, past or current heavy smokers). Participants will be randomised to one of three groups: Picture narrative format, Text with pictures (control 1) or, Text-only (control 2). This study will assess whether presenting lung screening information in a picture narrative format can improve lung cancer screening knowledge, eligibility self-assessment and attitudes. It will also assess whether perceptions of the information designs can explain any impact of the intervention on these outcomes and whether there are differences across socioeconomic groups.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 3
- Model description
- Participants are randomly assigned to one of three groups. They will receive the same lung screening information but the format of this information will be determined by which group they have been randomised to. All participants will complete a questionnaire immediately after viewing the lung screening information.
| Arm | Type | Receives |
|---|---|---|
| Picture narrative lung screening information | Experimental | Behavioral: Picture narrative information formatParticipants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format which uses text in combination with sequences of pictures to communicate a coherent message. The designs follow conventions from comics/graphic narratives and key stakeholders were involved during the design process. |
| Text with pictures lung screening information | Active comparator | Behavioral: Text with pictures information formatParticipants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text with non-narrative pictures for decoration. The pictures have been extracted from the picture narratives being used Arm 1. |
| Text-only lung screening information | Active comparator | Behavioral: Text-only information formatParticipants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text and no pictures. |
Who may qualify
- Ages
- 49 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Living in Glasgow
- Willing and able to respond unaided to invitation to participate in the trial and give informed consent.
- Aged between 49 and 75 years
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Picture narrative information formatLung screening information formatted as picture narratives | Behavioural | Picture narrative lung screening information |
| Text with pictures information formatLung screening information formatted as text and non-narrative pictures | Behavioural | Text with pictures lung screening information |
| Text-only information formatLung screening information formatted as text with no pictures | Behavioural | Text-only lung screening information |
Primary outcome
Participant Lung Cancer Screening Knowledge scores
Time frame: Immediately post-intervention
Participants will be asked 6 multiple choice questions related to the lung screening information presented to the participants during the intervention, covering; Procedure, Eligibility - who, Eligibility - why, Benefits, Adverse effects, Potential results.
Lung Cancer Screening Eligibility self-assessment
Time frame: Immediately post-intervention
Concordance between self-reported personal eligibility for lung cancer screening and actual eligibility based on self-reported age and smoking behaviour.
Participant Lung Cancer Screening Attitudes
Time frame: Immediately post-intervention
Self-administered four-item lung cancer screening attitudes measure covering cancer fear, fatalism, benefits, and worry, previously used by Smits et al 2018.
1 secondary outcome
Participant Design appraisal ratings
Time frame: Immediately post-intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2021.
- Individual participant dataSharing planned: Yes. Anonymised individual level study data will be shared via the University of Glasgow's repository Enlighten: Research Data.
Related trials for Cancer Screening
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Not yet recruitingObservational study
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Smoking Cessation, Lung Cancer Screening
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingObservational study
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
Pancreatic Cancer, Advanced or Metastatic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kathryn Robb, PhD principal investigator
University of Glasgow
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Picture narrative information format, Text with pictures information format and Text-only information format in people with Cancer Screening, run by University of Glasgow at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant Lung Cancer Screening Knowledge scores (time frame: Immediately post-intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2021.